Hematologic Malignancy

Review Article

Strategic innovations: Tackling challenges of immunotherapy in acute myeloid leukemia
Haolong Lin,Tao Wang,Jia Wei
Pages: 490-504 HTML
Bridging transplantation and immunotherapy: Clinical promise of autologous stem cell transplantation with chimeric antigen receptor T-cell therapy
Yixin Yan,Zigang Dai,Dengju Li,Xia Mao,Liang Huang
Pages: 505-520 HTML

Original Article

Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD acute myeloid leukemia patients: A multi-center, retrospective study
Yeqian Zhao,Chuanhe Jiang,Yi Luo,Guifang Ouyang,Lieguang Chen,Jian Yu,Yamin Tan,Xiaoyu Lai,Lizhen Liu,Huarui Fu,Yishan Ye,Luxin Yang,Congxiao Zhang,Jimin Shi,He Huang,Xiaoxia Hu,Yanmin Zhao
Pages: 521-533 HTML
Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study
Yuewen Wang,Lanping Xu,Yu Wang,Xiaohui Zhang,Kaiyan Liu,Yuanyuan Zhang,Chenhua Yan,Huan Chen,Yuhong Chen,Wei Han,Fengrong Wang,Jingzhi Wang,Xiaojun Huang,Yingjun Chang
Pages: 534-546 HTML
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group
Qi Wen,Chuanhe Jiang,Xiaodan Liu,Yi Xia,Yilei Ma,Yang Yang,Yu Wang,Yingjun Chang,Luxiang Wang,Zilu Zhang,Xiaojun Huang,Yang Cao,Yanmin Zhao,Xiaoxia Hu,Xiaodong Mo
Pages: 417-431 HTML
Quality-adjusted time without symptoms or toxicity analysis of haploidentical-related donor vs. identical sibling donor hematopoietic stem cell transplantation in acute myeloid leukemia
Yuewen Wang,Xianli Gao,Ting Wang,Xiaohui Zhang,Lanping Xu,Yu Wang,Chenhua Yan,Huan Chen,Yuhong Chen,Wei Han,Fengrong Wang,Jingzhi Wang,Xia Yan,Xiaodong Mo,Xiaojun Huang
Pages: 530-544 HTML

Commentary

Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives
Yi Fan,Jia Chen
Pages: 547-550 HTML
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia
Yiling Ye,Qifa Liu,Hua Jin
Pages: 551-553 HTML

Correspondence

Outcomes of adult patients with B-cell acute lymphoblastic leukemia with or without blinatumomab as bridging therapy prior to allogeneic hematopoietic stem cell transplantation
Jiayu Huang,Yi Xia,Yuhang Cheng,Bingyang Shi,Yilei Ma,Ze Tian,Luxiang Wang,Chuanhe Jiang,Haiyang Lu,Weijie Cao,Yang Cao,Xiaodong Mo,Xiaoxia Hu
Pages: 554-557 HTML